\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ steroid\\ therapy\\ with\\ significant\\ improvement\\ in\\ clinical\\ symptoms\\.\ \(0\)\
\-\ brain\\:\ \(8\)\
\-\ multiple\\ hemispheric\\ lesions\\ with\\ increased\\ signal\\ on\\ t2\\ and\\ flair\\ images\\.\\ lesions\\ have\\ no\\ mass\\ effect\\.\\ \\ no\\ restricted\\ diffusion\\.\ \(0\)\
\-\ mild\\ diffuse\\ enhancement\\ noted\\ following\\ contrast\\ administration\\.\ \(0\)\
\-\ cervical\\ spine\\:\ \(19\)\
\-\ enlarged\\ cervical\\ spinal\\ cord\\ with\\ increased\\ signal\\ on\\ t2\\ and\\ flair\\ images\\.\\ marked\\ enhancement\\ noted\\ following\\ contrast\\ administration\ \(0\)\
\-\ acute\\ disseminated\\ encephalomyelitis\\ \\(adem\\)\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ sclerosis\ \(0\)\
\-\ \\â\\€\\¢\\ pres\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ 5\\ year\\ old\\ boy\\ with\\ recent\\ history\\ of\\ gastroenteritis\\.\\ \\ now\\ presents\\ with\\ altered\\ mental\\ status\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ flair\\:\\ 0\\.08247744471611762\ \(0\)\
\-\ administration\\:\\ 0\\.07468758452427726\ \(0\)\
\-\ hemispheric\\:\\ 0\\.06579546385794696\ \(0\)\
\-\ cervical\\:\\ 0\\.06537034540192903\ \(0\)\
\-\ pres\\:\\ 0\\.06428913918804513\ \(0\)\
\-\ gastroenteritis\\:\\ 0\\.06180083626105324\ \(0\)\
\-\ encephalomyelitis\\:\\ 0\\.0602576417958756\ \(0\)\
\-\ disseminated\\:\\ 0\\.05478526854023446\ \(0\)\
\-\ adem\\:\\ 0\\.05423112397723002\ \(0\)\
\-\ following\\:\\ 0\\.051058479092655755\ \(0\)\
\-\ altered\\:\\ 0\\.051002384320151334\ \(0\)\
\-\ t2\\:\\ 0\\.050917658289481096\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.049484663734606985\ \(0\)\
\-\ enhancement\\:\\ 0\\.04822081612890602\ \(0\)\
\-\ lesions\\:\\ 0\\.04815916855460942\ \(0\)\
\-\ steroid\\:\\ 0\\.047488982429077134\ \(0\)\
\-\ signal\\:\\ 0\\.04743314379521639\ \(0\)\
\-\ increased\\:\\ 0\\.04401020593262433\ \(0\)\
\-\ noted\\:\\ 0\\.04264044607268618\ \(0\)\
\-\ improvement\\:\\ 0\\.041970575649096814\ \(0\)\
\-\ mental\\:\\ 0\\.041970575649096814\ \(0\)\
\-\ restricted\\:\\ 0\\.04139701580400134\ \(0\)\
\-\ contrast\\:\\ 0\\.040268961827534845\ \(0\)\
\-\ diffusion\\:\\ 0\\.040264061444081706\ \(0\)\
\-\ multiple\\:\\ 0\\.037890652704826715\ \(0\)\
\-\ marked\\:\\ 0\\.035103994743415856\ \(0\)\
\-\ images\\:\\ 0\\.03451081877788114\ \(0\)\
\-\ cord\\:\\ 0\\.03418077810742528\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.033221433770598705\ \(0\)\
\-\ sclerosis\\:\\ 0\\.03230858140448784\ \(0\)\
\-\ spinal\\:\\ 0\\.03220817063557459\ \(0\)\
\-\ status\\:\\ 0\\.0321087086440174\ \(0\)\
\-\ effect\\:\\ 0\\.03184798161125521\ \(0\)\
\-\ now\\:\\ 0\\.030748585154754184\ \(0\)\
\-\ enlarged\\:\\ 0\\.03069074810930533\ \(0\)\
\-\ boy\\:\\ 0\\.030576018736062853\ \(0\)\
\-\ recent\\:\\ 0\\.03023914788252418\ \(0\)\
\-\ spine\\:\\ 0\\.029622142589529978\ \(0\)\
\-\ clinical\\:\\ 0\\.027676945263852677\ \(0\)\
\-\ diffuse\\:\\ 0\\.02723165705658226\ \(0\)\
\-\ brain\\:\\ 0\\.02706685814002907\ \(0\)\
\-\ 5\\:\\ 0\\.026317478130991192\ \(0\)\
\-\ significant\\:\\ 0\\.024187864747939193\ \(0\)\
\-\ therapy\\:\\ 0\\.024048850486743295\ \(0\)\
\-\ \\:\\:\\ 0\\.023795259284014\ \(0\)\
\-\ mild\\:\\ 0\\.02368687846243302\ \(0\)\
\-\ metastatic\\:\\ 0\\.022643256880169372\ \(0\)\
\-\ symptoms\\:\\ 0\\.02241744712524357\ \(0\)\
\-\ acute\\:\\ 0\\.022209256095857843\ \(0\)\
\-\ have\\:\\ 0\\.01947829556173781\ \(0\)\
\-\ presents\\:\\ 0\\.018375203110609747\ \(0\)\
\-\ no\\:\\ 0\\.01811461369902741\ \(0\)\
\-\ on\\:\\ 0\\.01523981078664059\ \(0\)\
\-\ disease\\:\\ 0\\.014702500433849517\ \(0\)\
\-\ mass\\:\\ 0\\.012510115862605942\ \(0\)\
\-\ history\\:\\ 0\\.012423310923232457\ \(0\)\
\-\ year\\:\\ 0\\.01006426599234647\ \(0\)\
\-\ old\\:\\ 0\\.009209837861707943\ \(0\)\
\-\ \\(\\:\\ 0\\.0076038076446722155\ \(0\)\
\-\ \\)\\:\\ 0\\.0075109230748768956\ \(0\)\
\-\ with\\:\\ 0\\.006158114531046828\ \(0\)\
\-\ in\\:\\ 0\\.004435760317265842\ \(0\)\
\-\ and\\:\\ 0\\.00378966327857302\ \(0\)\
\-\ \\.\\:\\ 0\\.002989434618723897\ \(0\)\
\-\ of\\:\\ 0\\.0012263557978735623\ \(0\)\
